High-Negative Anti- Helicobacter pylori IgG Antibody Titers and Long-Term Risk of Gastric Cancer: Results from a Large-Scale Population-Based Cohort Study in Japan

Serologic testing of anti- antibody, together with testing of pepsinogen I and II, is now widely used to stratify groups at high risk of gastric cancer in Japan. Those with a negative anti- IgG titer, especially "high-negative" (3-

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2020-02, Vol.29 (2), p.420-426
Hauptverfasser:	Inoue, Manami, Sawada, Norie, Goto, Atsushi, Shimazu, Taichi, Yamaji, Taiki, Iwasaki, Motoki, Tsugane, Shoichiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Bacterial - blood Antibodies, Bacterial - immunology Female Follow-Up Studies Gastritis, Atrophic - blood Gastritis, Atrophic - diagnosis Gastritis, Atrophic - microbiology Gastritis, Atrophic - pathology Helicobacter Infections - blood Helicobacter Infections - diagnosis Helicobacter Infections - microbiology Helicobacter Infections - pathology Helicobacter pylori - immunology Helicobacter pylori - isolation & purification Humans Immunoglobulin G - blood Immunoglobulin G - immunology Japan - epidemiology Male Middle Aged Pepsinogen A - blood Pepsinogen C - blood Prospective Studies Risk Assessment Serologic Tests Severity of Illness Index Stomach Neoplasms - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Serologic testing of anti- antibody, together with testing of pepsinogen I and II, is now widely used to stratify groups at high risk of gastric cancer in Japan. Those with a negative anti- IgG titer, especially "high-negative" (3-
ISSN:	1055-9965 1538-7755
DOI:	10.1158/1055-9965.EPI-19-0993